title: [Cryptosporidium infection: value of a protease inhibitor].
authors.forename: B
authors.initials: B
authors.lastname: Contamin
authors.forename: A
authors.initials: A
authors.lastname: Boibieux
authors.forename: M
authors.initials: M
authors.lastname: Gérard-Boncompain
authors.forename: D
authors.initials: D
authors.lastname: Bouhour
authors.forename: V
authors.initials: V
authors.lastname: Girault
authors.forename: F
authors.initials: F
authors.lastname: Biron
authors.forename: D
authors.initials: D
authors.lastname: Peyramond
mesh_terms: D017088:AIDS-Related Opportunistic Infections / Q000188:drug therapy; D003457:Cryptosporidiosis / Q000188:drug therapy* / Q000209:etiology; D015658:HIV Infections / Q000150:complications*; D017320:HIV Protease Inhibitors / Q000627:therapeutic use*; D006679:HIV Seropositivity; D006801:Humans; D019469:Indinavir / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged
chemical_list: D017320:HIV Protease Inhibitors; D019469:Indinavir